Canada Goose acquires first European manufacturing plant in Romania, stock pops premarket
Canada Goose Holdings Inc.'s stock (GOOS) rose 2.8% premarket Tuesday, after the maker of luxury outerwear said it's acquired it's first manufacturing facility in Europe. The plant called Paola Confectii is based in Romania and has been a partner in making luxury knitwear for Canada Goose since its launch in 2017. The plan already makes best-selling products such as the HyBridge Knit Jacket, said Canada Goose. Knitwear is one of the company's leading segments in its apparel category and exceeded $70 million in annual sales in fiscal 2023. "Our core down-filled products will continue to be proudly made in Canada, while apparel production will continue to be concentrated within best-in-class European facilities," the company said in a statement. Paola Confectii will continue to be led by Giannino Lessi, general manager, and Paola Zaffalon, technical director, as a standalone entity. The stock has fallen 40% in the year to date, while the S&P 500 has gained 18.5%.
-Ciara Linnane
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
11-28-23 0709ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
Undervalued by 25% and Yielding 5%, This Stock Is a Buy
-
Can AI Predict Future Stock Returns?
-
The Best Energy Stocks to Buy Now
-
10 Undervalued Wide-Moat Stocks
-
Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk?
-
New 4-Star Stocks
-
Intel Fair Value Left Unchanged Despite Qualcomm Takeover Talk